REACTIVE AMYLOID A PROTEIN AMYLOIDOSIS IN THE SETTING OF INFECTIVE ENDOCARDITIS MANIFESTING AS BILATERAL ORBITOPATHY AND CHOROIDOPATHY
- PMID: 33394958
- DOI: 10.1097/ICB.0000000000001112
REACTIVE AMYLOID A PROTEIN AMYLOIDOSIS IN THE SETTING OF INFECTIVE ENDOCARDITIS MANIFESTING AS BILATERAL ORBITOPATHY AND CHOROIDOPATHY
Abstract
Purpose: To describe a case of amyloid A protein amyloidosis that produced an orbital inflammatory response with a novel presentation.
Methods: Case report.
Results: A 24-year-old Caucasian women with a history of intravenous heroin use was hospitalized for tricuspid valve endocarditis and methicillin-resistant Staphylococcus aureus bacteremia, as well as acute renal failure. She received hemodialysis and intravenous daptomycin and had negative blood cultures for 3 weeks, when she developed sudden bilateral orbital swelling and blurred vision. Visual acuity was 20/200 in the right eye and 20/400 in the left eye. Examination revealed proptosis, conjunctival chemosis and desiccation, optic disk swelling, creamy choroidal infiltrates, and inferiorly located exudative retinal detachments in both eyes. Multimodal imaging demonstrated thickening of the sclera, choroid, and choriocapillaris as well as outer retinal disruption, subretinal fluid, and deposits of hyperfluorescent debris within the choriocapillaris, outer retina, and vitreous. Oral prednisone at 60 mg per day resolved the choroidal infiltrates and exudative detachments. Persistent nephrotic syndrome called for a renal biopsy, which demonstrated amyloid A protein amyloidosis.
Conclusion: Orbital and choroidal Amyloid A protein amyloidosis can induce a local inflammatory response manifesting as orbital swelling, papillitis, posterior scleritis, choroiditis, and exudative retinal detachment, which responds to steroid therapy. The underlying pathology is likely a reactive inflammatory, vasoocclusive process involving the choriocapillaris and orbital vasculature to the presence of amyloid fibrils.
References
-
- Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol 2015;10:321–344.
-
- Papa R, Lachmann HJ. Secondary AA amyloidosis. Rheum Dis Clin North Am 2018;44:585–603.
-
- Sharma A, Govindan P, Toukatly M, et al. Heroin use is associated with AA-type kidney amyloidosis in the Pacific Northwest. Clin J Am Soc Nephrol 2018;13:1030–1036.
-
- Lejmi H, Jen KY, Olson JL, et al. Characteristics of AA amyloidosis patients in san Francisco. Nephrology (Carlton) 2016;21:308–313.
-
- Blandford AD, Yordi S, Kapoor S, et al. Ocular adnexal amyloidosis: a mass spectrometric analysis. Am J Ophthalmol 2018;193:28–32.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical